Media stories about Henry Schein (NASDAQ:HSIC) have trended somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Henry Schein earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media headlines about the company an impact score of 45.9918469980572 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

These are some of the media headlines that may have impacted Accern Sentiment’s rankings:

Several research analysts have issued reports on HSIC shares. Zacks Investment Research raised Henry Schein from a “hold” rating to a “buy” rating and set a $206.00 price target on the stock in a report on Friday, June 16th. Northcoast Research raised Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price target on the stock in a report on Monday, August 7th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $177.00 price target on shares of Henry Schein in a report on Friday, July 21st. Credit Suisse Group reaffirmed a “hold” rating and issued a $160.00 price target on shares of Henry Schein in a report on Thursday, July 13th. Finally, Stifel Nicolaus reaffirmed a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $186.50.

Shares of Henry Schein (HSIC) traded up 0.05% during mid-day trading on Wednesday, reaching $172.44. 523,006 shares of the company’s stock traded hands. Henry Schein has a 52 week low of $146.23 and a 52 week high of $186.99. The firm has a market cap of $13.63 billion, a price-to-earnings ratio of 25.20 and a beta of 1.10. The company’s 50 day moving average is $175.51 and its 200-day moving average is $176.27. Shares of Henry Schein are set to split on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly created shares will be distributed to shareholders after the market closes on Thursday, September 14th.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The company had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. During the same quarter last year, the firm posted $1.64 EPS. The company’s quarterly revenue was up 6.4% on a year-over-year basis. Equities analysts expect that Henry Schein will post $7.27 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Somewhat Positive Media Coverage Somewhat Unlikely to Impact Henry Schein (HSIC) Stock Price” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/09/07/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-henry-schein-hsic-stock-price.html.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Insider Buying and Selling by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.